Chemical Property of (S)-5-chloro-N2-(1-(5-fluoropyrimidin-2-yl)ethyl)-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine
Chemical Property:
- Boiling Point:575.2±60.0 °C(Predicted)
- PKA:13.73±0.10(Predicted)
- PSA:107.53000
- Density:1.517 g/cm3
- LogP:2.50220
- Storage Temp.:-20°C
- Solubility.:Chloroform (Slightly, Heated), DMSO (Slightly, Heated), Methanol (Slightly, Heat
- XLogP3:2.4
- Hydrogen Bond Donor Count:3
- Hydrogen Bond Acceptor Count:8
- Rotatable Bond Count:5
- Exact Mass:348.1013983
- Heavy Atom Count:24
- Complexity:397
- Purity/Quality:
-
99% *data from raw suppliers
AZD1480 *data from reagent suppliers
Safty Information:
- Pictogram(s):
- Hazard Codes:
- MSDS Files:
-
SDS file from LookChem
Useful:
- Canonical SMILES:CC1=CC(=NN1)NC2=NC(=NC=C2Cl)NC(C)C3=NC=C(C=N3)F
- Isomeric SMILES:CC1=CC(=NN1)NC2=NC(=NC=C2Cl)N[C@@H](C)C3=NC=C(C=N3)F
- Recent ClinicalTrials:Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative Diseases
- Recent EU Clinical Trials:A Phase I/II, Open Label Multi-Centre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the JAK2 inhibitor AZD1480 Administered Orally to Patients with Primary Myelofibrosis (PMF) and Post-Polycythaemia Vera/Essential Thrombocythaemia Myelofibrosis (Post-PV/ET MF)
-
Uses
AZD1480 has been used as an inhibitor of janus kinase 2 (JAK2) and signal transducer and activator of transcription 3 (STAT3) in an in vitro cell model of upper gastrointestinal adenocarcinoma. It has also been used in combination with bortezomib to study tumor-associated macrophage-mediated survival of myeloma cells.